Zimmer Spine's FDA clearance for its Optio-C Anterior Cervical Plate

Written by Anuja Vaidya | November 10, 2014 | Print  |

Zimmer Spine received 510(k) clearance from the U.S. Food and Drug Administration for its Optio-C Anterior Cervical Plate.

The plate is intended for use with structural allograft/autograft as a stand-alone cervical system for cervical fusion procedures. The device is secured by an anti-migration system that is designed to maintain no profile.


Zimmer Spine focuses on developing comprehensive surgical solutions, training and clinical support that advance and support spine surgeons.

More articles on devices:

LDR, Wright Medical, NuVasive & more — 15 key notes
Halifax Biomedical names Allan Pozdol vice president of sales
SpineFrontier to manufacture an intervertebral body fusion device with Invibio's PEEK-OPTIMA HA Enhanced

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies here.

Featured Webinars

Featured Whitepapers